41
Participants
Start Date
June 1, 2021
Primary Completion Date
July 31, 2024
Study Completion Date
July 31, 2024
Aflibercept Injection
Intravitreal 2mg aflibercept injection
Cumberland Valley Retina Consultants, P.C., Hagerstown
Palmetto Retina Center, West Columbia
Palmetto Retina Center, LLC - Florence, Florence
Marietta Eye Clinic, Marietta
Central Florida Retina Center, Orlando
Center for Retina and Macular Disease, Winter Haven
Charles Retina Institute, Germantown
John Kenyon American Eye Institute, New Albany
Dean McGee Eye Institute, Oklahoma City
Strategic Clinical Research Group, LLC, Willow Park
Retina Consultants of Texas, Bellaire
Valley Retina Institute, Harlingen
Retina Vitreous Associates Medical Group, Beverly Hills
Emanuelli Research and Development Center, LLC, Arecibo
Regeneron Pharmaceuticals
INDUSTRY
Clinical Trials Resource Group, LLC
UNKNOWN
Greater Houston Retina Research
OTHER